Zevra Therapeutics Inc. (ZVRA) valuation · P/E 11, rev $106.5M
Zevra Therapeutics Inc. (ZVRA) P/E 11, rev $106.5M.
| Metric | Value |
|---|---|
| P/E | 11 |
| Market cap | $745.4M |
| Revenue | $106.5M |
| P/S | 7.0 |
| P/B | 3.6 |
ZVRA valuation FAQ
What is ZVRA's P/E ratio?
Zevra Therapeutics Inc. (ZVRA) trailing P/E is 11 on the latest cached fundamentals snapshot.
What is ZVRA's market cap?
Zevra Therapeutics Inc. (ZVRA) market cap is $745.4M on the latest cached fundamentals snapshot.
What is ZVRA's latest revenue?
Latest cached Zevra Therapeutics Inc. (ZVRA) revenue was $106.5M. Statements: https://lician.com/financials/zvra
What is ZVRA's price-to-sales ratio?
Zevra Therapeutics Inc. (ZVRA) price-to-sales (P/S) is 7.0, cached market cap $745.4M divided by revenue $106.5M.
What is ZVRA's price-to-book ratio?
Zevra Therapeutics Inc. (ZVRA) price-to-book (P/B) is 3.6 on the latest cached fundamentals snapshot.
How many ZVRA valuation scalars are listed on this page?
This page lists 5 cached valuation scalars for Zevra Therapeutics Inc. (ZVRA): P/E, Market cap, Revenue, P/S, and P/B.
Where is ZVRA valuation listed?
Cached valuation multiples for Zevra Therapeutics Inc. (ZVRA) are listed at https://lician.com/valuation/zvra.
Not investment advice. Cached rows, not a live tape.